Carnosine, diabetes and Alzheimer's disease

Expert Review of Neurotherapeutics

Volumn 9, Issue 5, 2009, Pages 583-585

  Hipkiss, Alan R ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARNOSINE;

ALZHEIMER DISEASE; CELL AGING; DIABETIC NEPHROPATHY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; DRUG POTENCY; DRUG SYNTHESIS; EDITORIAL; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; GLYCATION; HUMAN; KIDNEY DISEASE; LIPID PEROXIDATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN;

ALZHEIMER DISEASE; ANIMALS; ANTIOXIDANTS; CARNOSINE; DIABETES COMPLICATIONS; HUMANS;

EID: 66249112835     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.09.32     Document Type: Editorial

References (56)

1. Maher P, Schubert D. Metabolic links between diabetes and Alzheimer's disease.Expert Rev. Neurother. 9(5), 617-630 (2009).
2. Hipkiss AR. Accumulation of altered proteins and ageing: causes and effects.Expt. Gerontol. 41, 464-473 (2006).
3. Bonfanti L, Peretto P, de Marchis S, Fasolo A. Carnosine-related dipeptides in the mammalian brain.Prog. Neurobiol. 59, 333-353 (1999).
4. Quinn PJ, BoldyrevAA, Formazuyk VE. Carnosine: its properties, functions and potential therAβeutic Aβplications.Mol. Aspects Med. 13, 379-444 (1992).
5. Bauer K. Carnosine and homocarnosine, the forgotten, enigmatic peptides of the brain.Neurochem. Res. 30, 1339-1345 (2005).
6. Hipkiss AR. Would carnosine or a carnivorous diet help suppress aging and associated pathologies?Ann. NYAcad. Sci. 1067, 369-374 (2006).
7. Hipkiss AR. Glycation, ageing and carnosine: are carnivorous diets beneficial?Meek AgeingDev. 126, 1034-1039 (2005).
8. Hipkiss AR. Could carnosine or related structures suppress Alzheimer's disease?J. Akheimers Dis. 11, 229-240 (2007).
9. Kohen R, Yamamoto Y, Cundy KC, Ames BN. Antioxidant activity of carnosine, homocarnosine and anserine present in muscle and brain.Proc. Natl Acad. Sci. USA 95, 2175-2179 (1988).
10. Bogardus SL, Boissonneault GA. Carnosine inhibitsin vitro low-density lipoprotein oxidation.Nutr. Res. 20, 967-976 (2000).
11. Calabrese V, Coombrita C, Guagliano Eet al. Protective effect of carnosine during nitrosactive stress in astroglial cell cultures.Neurochem. Res. 30, 797-807 (2005).
12. Hipkiss AR, Michaelis J, Syrris P. Non-enzymic glycosylation of the dipeptide L-carnosine, a potential anti-protein-cross-linking agent.FEBS Lett. 371, 81-85 (1995).
13. Yan H, Harding JJ. Carnosine protects against the inactivation of esterase induced by glycation and a steroid.Biochim. Biophys. Acta 1741, 120-126 (2005).
14. Seidler NW. Carnosine prevents glycation-induced changes in electrophoretic mobility of aspartate aminotransferase.J. Biochem. Mol. Toxicol. 14, 215-220 (2000).
15. Baran EL. Metal complexes of carnosine.Biochem. (Moscow) 65, 789-797 (2000).
16. Hipkiss AR, Chana H. Carnosine protects proteins against methylglyoxal-mediated modifications.Biochem. Biophys. Res. Commun. 248, 28-32 (1998).
17. Brownson C, Hipkiss AR. Carnosine reacts with a glycated protein.Free Radic. Biol. Med. 28, 1564-1570 (2000).
18. Battah S, Ahmed N, Thornalley PJ. Novel anti-glycation therAβeutic agents: glyoxalase-1-mimetics.Int. Congr. Ser. 1245, 107-111 (2002).
19. Hipkiss AR, Preston JE, Himsworth DT, Worthington VC, Abbott NJ. Protective effects of carnosine against malondialdehyde-induced toxidty towards cultured rat brain endothelial cells.Neurosa. Lett. 238,135-138 (1997).
20. Aldini G, Carini M, Beretta G, Bradamante S, Facino RB. Carnosine is a quencher of 4-hydroxynonenal: though what is the mechanism of reaction?Biochem. Biophys. Res. Commun. 298, 699-706 (2002).
21. Carini M, Aldini G, Beretta G, Arlandini E, Facino RM. Acrolein-sequestering ability of endogenous dipeptides: characterization of carnosine and homocarnosine/acrolein adducts by electrospray ionization tandem mass spectrometry.J. Mass Spec. 38, 996-1006 (2003).
22. Aldini G, Maffei-Fracino R, Beretta G, Carini M. Carnosine and related dipeptides as quenchers of reactive carbonyl species: from structural studies to therAβeutic perspectives.BioFactors 24, 77-87 (2005).
23. Hipkiss AR, Preston JE, Himsworth DTMet al. Pluripotent protective effects of carnosine, a naturally-occurring dipeptide.Ann. NYAcad. Sci. 854, 37-53 (1998).
24. Hipkiss AR, Brownson C, Carrier MJ. Carnosine, the anti-ageing, anti-oxidant dipeptide, may react with protein carbonyl groups.Meek Ageing Dev. 122, 1431-1445 (2001).
25. McFarland GA, Holliday R. Retardation of senescence in cultured human diploid fibroblasts by carnosine.Exp. Cell Res. 212, 167-175 (1994).
26. McFarland GA, Holliday R. Further evidence for the rejuvenating effects of the dipeptide L-carnosine on cultured diploid fibroblasts.Exp. Geront. 34, 35-45 (1999).
27. Yuneva MO, Bulygina ER, Gallant SC,et al. Effect of carnosine on age-induced changes in senescence-accelerated mice.J. AntiAgingMed. 2, 337-342 (1999).
28. Yuneva AO, Kramarenko GG, Vetreshchak TV, Gallant S, Boldyrev AA. Effect of carnosine onDrosophila melanogaster lifespan.Bull. Expt. Biol. Med. 133, 559-561 (2002).
29. Preston JP, Hipkiss AR, Himsworth DJT, Romero IA, Abbott JN. Toxic effects of β-amyloid (25-35) on immortalised rat brain endothelial cells: protection by carnosine, homocarnosine and β-alanine.Neurosa. Lett. 242, 105-108 (1998).
30. Boldyrev AA, Koudinov A, Berezov T, Carpenter DO. Amyloid-β induced cell death is independent of free radicals.J. Alzheimer Dis. 6, 633-638 (2004).
31. Fu Q, Dai H, Hu Wet al. Carnosine protects against Aβ42-induced neurotoxicity in differentiated rat PC12 cells.Cell. Mol. Neurobiol. 28, 307-316 (2008).
32. Lee Y, Hsu C, Lin K, Yin M. Histidine and carnosine delay diabetic deterioration in mice and protect human low density lipoprotein against oxidation and glycation.Eur.J. Pharmacol. 512, 145-150 (2005).
33. Sauerhoefer S, Yuan G, Braun GSet al. L-carnosine, a substrate for carnosinase-1, influences glucose metabolism.Diabetes 56, 2425-2432 (2007).
34. Janssen B, Hohenadel D, Brinkkoeter Pet al. Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase geneCNDP1. Diabetes 54, 2320-2327 (2005).
35. Freedman BI, Hicks PJ, Sale MMet al. A leucine repeat in the carnosinase geneCNDP1 is associated with diabetic end-stage renal disease in European Americans.Nephrol. Dial. Transplant. 22, 1131-1135 (2007).
36. Dobrota D, Fedorova T, Stvolinsky SLet al. Carnosine protects the brain of rats and Mongolian gerbils against ischemic injury: after-stroke-effect.Neurochem. Res. 30, 1283-1288 (2005).
37. Fouad AA, El-Rehany MA, Maghraby HK. The hepatoprotective effect of carnosine against ischemia/reperfusion liver injury in rats.Eur. J. Pharmacol. 572, 61-68 (2007).
38. Fujii T, Takaoka M, Tsuruoka N, Kiso Y, Matsumura Y. Dietary supplemention with L-carnosine prevents ischemia/reperfusion renal injury in rats.Biol. Pharm. Bull. 28, 361-363 (2005).
39. Gallant S, Kukley M, Stvolinsky S, Bulgina E, Boldyrev AA. Effect of carnosine on rats under experimental ischemia.Tohoku J. Exp. Med. 191, 85-99 (2000).
40. Hipkiss AR. Carnosine, a protective anti-ageing peptide?Int. J. Biochem. Cell Biol. 30, 863-868 (1998).
41. Boldyrev, AA, Gallant SC, Sukhich GT. Carnosine, the protective, anti-ageing peptide.Biosci. Rep. 19, 581-587 (1999).
42. Hipkiss AR. On the enigma of carnosine's anti-ageing actions.Expt. Gerontol. 44, 237-242 (2009).
43. Stuerenburg HJ, Kunze K. Concentrations of free carnosine (a putative membrane-protective antioxidant) in human muscle and rat muscles.Arch. Geront. Geriat. 29, 107-113 (1999).
44. Johnson P, Hammer JL. Histidine dipeptide levels in aging and hypertensive rat skeletal and cardiac muscles.Comp. Biochem. Physiol. B Biochem. Mol. Biol. 103, 981-984 (1992).
45. Tallon MJ, Harris RC, Maffulli N, Tarnopolsky MA. Carnosine, taurine and enzyme activities of human skeletal muscle fibres from elderly subjects with osteoarthritis and young moderately active subjects.Biogerontology 8, 129-137 (2007).
46. Jansen EEW, Gibson KM, Shigematsu Y, Jakobs C, Verhoeven NM. A novel, quantitative assay for homocarnosine in cerebrospinal fluid using stable-isotope dilution liquid chromatogrAβhy-tandem mass spectrometry.J. Chromatog. B Analyt. Technol. Biomed. Life Sci. 830, 196-200 (2006).
47. Huang Y,DuanJ, Chen H, Chen M, Chen G. Separation and determination of carnosine-related peptides using cAβillary electrophoresis with laser-induced fluorescence detection.Electrophoresis 26, 593-599 (2005).
48. Yamagishi S, Nakamura K, Inoue H, Kikushi S, Takeuchi M. Serum and cerebrospinal fluid levels of glyceraldehyde-derived advanced glycation end products (AGEs) may be a promising biomarker for early detection of Alzheimer's disease.Med. Hyp. 64, 1205-1207 (2005).
49. Ahmed N, Ahmed U, Thornalley PJ, Hager K, Fleischer G, Munch G. Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment.J. Neurochem. 92, 255-263 (2005).
50. Shuvaev VV, Laffont I, Serot M, Fujii J, Taniguchi N, Siest G. Increased protein glycation in cerebrospinal fluid in Alzheimer's disease.Neurobiol. Aging22, 397-402 (2001).
51. Harris RC, Tallon MJ, Dunnett Met al. The absorption of orally supplied P-alanine and its effects on muscle carnosine synthesis in human vastus lateralis.Amino Acids 30, 279-289 (2006).
52. Barbizhayev MA. Ocular drug metabolism of the bioactivating antioxidant -/V-acetylcarnosine for vision in ophthalmic progrug and codrug design and delivery.Drug Dev. Ind. Pharm. 34, 1071-1089 (2008).
53. Petroff OA, Hyder F, Rothman DL, Mattson FH. Brain homocarnosine and seizure control of patients taking gabAβentin or topiramate. Epilepsia 47, 495-498 (2006).
54. Petroff OA, Mattson RH, Behar KL, Hyder F, Rothman DL. Vigabatrin increases human brain homocarnosine and improves seizure control.Ann. Neurol. 44, 948-952 (1998).
55. Hughes SE, Evason K, Xiong C, Kornfeld K. Genetic and pharmacological factors that influence reproductive aging in nematodes.PLoS Genet. 3, 254-265 (2007).
56. Evason K, Huang C, Yamben I, Covey DF, Kornfield K. Anticonvulsant medications extend worm life-span.Science 307, 258-262 (2005).